Log in

NASDAQ:PAHC - Phibro Animal Health Stock Price, Forecast & News

$24.56
+0.50 (+2.08 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$24.02
Now: $24.56
$24.65
50-Day Range
$21.08
MA: $23.27
$24.57
52-Week Range
$20.00
Now: $24.56
$36.98
Volume285,988 shs
Average Volume186,785 shs
Market Capitalization$993.53 million
P/E Ratio16.05
Dividend Yield2.00%
Beta0.82
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$828 million
Cash Flow$2.26 per share
Book Value$5.34 per share

Profitability

Net Income$54.71 million

Miscellaneous

Employees1,600
Market Cap$993.53 million
Next Earnings Date2/5/2020 (Estimated)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Monday, November 4th. Investors of record on Wednesday, November 27th will be paid a dividend of $0.12 per share on Wednesday, December 18th. This represents a $0.48 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date of this dividend is Tuesday, November 26th. View Phibro Animal Health's Dividend History.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) released its earnings results on Monday, November, 4th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.24 by $0.05. The company had revenue of $190 million for the quarter, compared to analysts' expectations of $199.22 million. Phibro Animal Health had a return on equity of 25.52% and a net margin of 4.99%. The firm's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.39 EPS. View Phibro Animal Health's Earnings History.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Phibro Animal Health.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health updated its FY20 earnings guidance on Monday, November, 4th. The company provided earnings per share guidance of $1.08-$1.14 for the period, compared to the Thomson Reuters consensus estimate of $1.12.

What price target have analysts set for PAHC?

5 analysts have issued 1-year target prices for Phibro Animal Health's shares. Their forecasts range from $18.00 to $42.00. On average, they expect Phibro Animal Health's share price to reach $26.60 in the next year. This suggests a possible upside of 8.3% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

What is the consensus analysts' recommendation for Phibro Animal Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

News articles about PAHC stock have been trending somewhat positive on Saturday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Phibro Animal Health earned a daily sentiment score of 1.9 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Phibro Animal Health.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zoetis (ZTS), Booking (BKNG), Ophthotech (OPHT), RetailMeNot (SALE) and Zynerba Pharmaceuticals (ZYNE).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the folowing people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (1.62%), Chartwell Investment Partners LLC (0.73%), Millennium Management LLC (0.73%), Eagle Asset Management Inc. (0.69%), Tocqueville Asset Management L.P. (0.68%) and Man Group plc (0.45%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Jack Bendheim and Larry Lee Miller. View Institutional Ownership Trends for Phibro Animal Health.

Which major investors are selling Phibro Animal Health stock?

PAHC stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Squarepoint Ops LLC and Dupont Capital Management Corp. Company insiders that have sold Phibro Animal Health company stock in the last year include Daniel M Bendheim and Dean J Warras. View Insider Buying and Selling for Phibro Animal Health.

Which major investors are buying Phibro Animal Health stock?

PAHC stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Tocqueville Asset Management L.P., Chartwell Investment Partners LLC, SG Americas Securities LLC, First Trust Advisors LP, Russell Investments Group Ltd., Oppenheimer Asset Management Inc. and Mackay Shields LLC. View Insider Buying and Selling for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $24.56.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $993.53 million and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is http://www.pahc.com/.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  266 (Vote Outperform)
Underperform Votes:  327 (Vote Underperform)
Total Votes:  593
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel